Investment Committee Summary
| Rating | BUY |
| Internal 5-tier | BUY |
| Classification · conviction | high-risk optionality · medium |
| Evidence | 8/8 load-bearing inputs sourced |
| Triangulated fair value | $554 (+47% vs spot · triangulated FV) |
| 12-mo scenario PWEV | $451 (+20% vs spot · 12m PWEV) |
| Next catalyst | 2026-09-09 — Ex-dividend $2.00/sh |
| Primary thesis-break | Combined ratio (reported, consolidated) > 100.0 (2 consecutive prints) |
Decision detail — rating tables & Research OS strip
Rating: BUY
Internal 5-tier: BUY · high-risk optionality · analyst conviction: medium
| Metric | Value |
|---|---|
| Current Price | $377 |
| Triangulated Fair Value | $554 (+47% vs spot · triangulated FV) |
| 12-mo Scenario PWEV | $451 (+20% vs spot · 12m PWEV) |
| Forward P/E | 5.8x |
| Market Cap | $14B |
| 52-Week Range | $297–$399 (high/low reconstructed from the stock's own adjusted-close history — the vendor's recorded range was stale) |
EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).
Methodology: Valuation triangulated across four weighted anchors — an intrinsic DCF, a scenario-weighted PWEV, a Monte Carlo median (Student-t + regime switching) and a peer P/E re-rate. Anchors that share a market multiple are not independent evidence and are weighted as one view. Figures reconciled to Alpha Vantage 2026-08-24. Each chart below sits with the part of the thesis it evidences.
General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.
Decision Support — Research OS jump to detail ↓
| Research conviction | Exp. return (1y) | Rules stance | Preferred options | Next catalyst |
|---|---|---|---|---|
| 60.7/100 (61st pct) | +20% 1yr expected | Hold | Long Stock | 15d — Ex-dividend $2.00/sh |
Research rating: BUY · Tactical / decision-rule stance: Hold — the stance is the machine decision-rules layer (hysteresis, kill-switches, freshness); the rating is the valuation verdict. They may diverge and are reconciled in the Decision Rules section below.
Full breakdown — conviction components, position sizing, probability-return distribution, decision rules, factor & portfolio interaction, options intelligence and the catalyst timeline — in the Decision Support sections below. Model output for research; not individualised advice.
📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.
Recommendation: BUY
Constructive: rating BUY and the triangulated fair value ($554, +47%) agree on upside; the debate is P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.
Investment Thesis
At $377 (25 August 2026) Everest changes hands at roughly 6x forward earnings: the tape is pricing a reinsurer whose reserve and catastrophe tail is unresolved, not a franchise earning a mid-cycle combined ratio. The engine's mid-cycle path assumes an operating margin near 17%, mid-single-digit premium growth and a modest float contribution, producing base earnings consistent with the simulated median. Against that, triangulation lands at $554, leaving the shares trading cheap to that anchor (+47%), and the probability-weighted expected value of $451 and twelve-month target of $454 also sit above the current quote, even though the model carries a heavy combined weight on the reserve-reset and soft-market states and applies a below-peer base multiple. The rating is BUY on that gap: the current valuation already discounts a soft cycle, and the 52-week low frames a reference floor rather than a destination. The single most damaging risk is reserve inadequacy: a further large prior-year US casualty strengthening would validate the reset path and compress earnings and the multiple at once.
Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.
The dashboard below is the whole argument on one page: spot ($377) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The bear mechanism is reserve and catastrophe reset, and it is not a token hedge. Everest has already taken sizeable prior-year US casualty reserve charges, and loss-cost inflation on long-tail liability lines can run ahead of booked assumptions for several years before it fully surfaces. If strengthening continues, the combined ratio stays above break-even, book value compounds slowly or shrinks, and the return on equity drops through the cost of equity. In that state the market is right to hold the multiple low rather than re-rate toward peers: a cheap multiple on impaired, still-uncertain earnings is rational pricing, not a mispricing waiting to be arbitraged. Catastrophe volatility layered on top can turn a single year sharply negative, and reinsurance recoveries do not arrive fast enough to smooth it. The cheap headline multiple then reflects genuine balance-sheet risk, and the structural path, below the 52-week low, becomes the central case rather than the tail.
Key Debate
P/E Multiple explains 51% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.
What the Market Is Pricing In
At the current price, the market pays 7.1× consensus forward EPS, and a peer median 10.3×.
Variant perception: the house view is above-consensus, and the thesis is primarily growth-driven.
| Metric | Consensus | House | Importance |
|---|---|---|---|
| Revenue | 12.4 | 18.2 | High |
| EPS | 53.3 | 64.9 | Medium |
| Target price | 406.5 | 454.2 | Medium |
Scenario Analysis
The scenario tree spans a structural 'Structural — Underwriting / Reserve / Catastrophe Reset' downside ($213) to a 'Bull — Re-Rate' bull case ($804); the probability-weighted blend (PWEV $451) is +20% versus spot.
| Scenario | Probability | Target | Return vs spot |
|---|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | 20% | $213 | -43% |
| Soft Market / Investment Loss | 17% | $333 | -12% |
| Base — Mid-Cycle Combined Ratio | 35% | $463 | +23% |
| Growth — Hard Market / Pricing + Float Income | 20% | $626 | +66% |
| Bull — Re-Rate | 8% | $804 | +113% |
| Probability-Weighted (PWEV) | — | $451 | +20% |
Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 0.4% of revenue; free cash flow net of SBC is $-0.06B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.
Scenario rationale — the driver path behind every target:
- Structural — Underwriting / Reserve / Catastrophe Reset (20%, $213). Structural impairment — underwriting / reserve / catastrophe reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
- Soft Market / Investment Loss (17%, $333). Cyclical downturn — premium growth + underwriting margin + investment income + reserves weakens for 1–2 years before normalising.
- Base — Mid-Cycle Combined Ratio (35%, $463). Mid-cycle — normalised premium growth + underwriting margin + investment income + reserves; disciplined capital allocation; steady returns.
- Growth — Hard Market / Pricing + Float Income (20%, $626). Upside — hard market + pricing lifts earnings above mid-cycle; the multiple expands modestly.
- Bull — Re-Rate (8%, $804). Upside tail — sustained tight conditions or a structural re-rate on hard market + pricing.
Valuation Triangulation
Four weighted anchors — an intrinsic dcf, a scenario-weighted pwev, a monte carlo median (student-t + regime switching) and a peer p/e re-rate — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat four numbers as four independent votes.
| Method | Basis | Fair Value | vs Spot | Weight in this name's blend |
|---|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $404 | +7% | 18% (declared 15%) |
| Peer P/E re-rate | multiple | $670 | +78% | 12% (declared 10%) |
| Peer EV/Revenue re-rate | multiple | $1,195 | +217% | 0% — cross-check only |
| Scenario PWEV | multiple | $451 | +20% | 29% (declared 25%) |
| Justified P/B (ROE-based) | book value × ROE | $660 | +75% | 41% (declared 35%) |
| Triangulated (weighted) | — | $554 | +47% | 100% |
The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts is not computed, so 15% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.
Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.
Book Value, ROE & Capital Returns
For a bank or insurer the cash-flow DCF is the wrong intrinsic anchor — capital is the product. Value is set by return on equity vs cost of equity against book value: the Gordon-justified multiple is P/B = (ROE − g) / (COE − g).
| Metric | Value |
|---|---|
| Book value / share | $384 |
| Return on equity (ROE) | 13.8% |
| Cost of equity (assumed) | 9.5% |
| Current P/B | 0.98x |
| Justified P/B (ROE-based) | 1.72x |
| Justified value / share | $660 (+75%) |
ROE of 13.8% comfortably clears the ~10% cost of equity — which is why a premium justified P/B of 1.72x (vs 0.98x current) is warranted. The justified value sits +75% vs spot; that gap, plus the credit / underwriting cycle in the scenarios, is the debate. The Monte Carlo and scenario PWEV carry the earnings (P/E) view; this block carries the book-value view.
Monte Carlo — the outcome distribution
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $404 and 56% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (51% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 10.3x) implies $670. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so market sentiment does not set the fair value.
Across all anchors the spread is 120% of the median — wide (genuine disagreement — the blend carries low valuation confidence).
Peer Quality & Weighting
| Peer | Fwd P/E | Growth | Op margin | Quality | Weight cap |
|---|---|---|---|---|---|
| GL | 10.4× | 5% | 24% | broad | 25% |
| AIZ | 10.2× | 5% | 11% | broad | 25% |
| ERIE | 26.7× | 7% | 17% | broad | 25% |
| IVZ | 9.9× | 6% | 19% | broad | 25% |
Quality-weighted forward P/E: 14.3× (simple median 10.3×). Direct peers count 100%, segment 50%, broad 25%.
Historical-range cross-check: 52-week range $297–$399, centre $344 (-9% vs spot); spot sits at the 78th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.
Risk / Reward & Margin of Safety
| Metric | Value |
|---|---|
| Upside to triangulated FV | $554 (+47% vs spot · triangulated FV) |
| Downside to bear case (Structural — Underwriting / Reserve / Catastrophe Reset) | $213 (-43% vs spot · bear scenario) |
| Reward/risk ratio | 1.1× |
| Margin of safety (FV vs spot) | +32% |
| P(price > spot) — Monte Carlo | 56% |
Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $804.
Company Overview & Business Model
Everest Group Ltd — FINANCIAL SERVICES · INSURANCE - REINSURANCE. Everest Group, Ltd., provides reinsurance and insurance products in the United States, Bermuda, and internationally. The company is headquartered in Hamilton, Bermuda.
How it makes money.
| Segment | Rev mix | Growth | Op margin | Key driver |
|---|---|---|---|---|
| Insurance (Underwriting + Float) | 100% | +5% | 17% | premium growth + underwriting margin + investment income + reserves |
Edge. Narrow moat. Authored moat rationale withheld pending re-authoring.
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | EBIT | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|---|
| Insurance (Underwriting + Float) | $17.3B | 100% | 5% | 17% | $3.0B | 7.0x | 1% | ESTIMATE |
| EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed). |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | premium growth + underwriting margin + investment income + reserves |
| net_debt_or_cash_b | -2.17 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.01 |
| div_yield | 0.0231 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | underwriting / reserve / catastrophe reset |
| upside | hard market + pricing |
Balance Sheet & Liquidity
| Metric | Value |
|---|---|
| Net debt | $-15.9B — net cash |
| Interest coverage (EBIT / interest) | 14.1x |
| Current ratio | 0.76x |
| Cash & ST investments | $19.5B |
Balance-sheet data as of 2025-12-31 (Alpha Vantage).
Capital Allocation
| Metric | Value |
|---|---|
| Free cash flow | $0.0B |
| Buybacks / dividends | $0.8B / $0.3B |
| Total shareholder yield | 8.1% |
| Reinvestment (capex / OCF) | 100.0% |
Free-Cash-Flow Quality
| Metric | Value |
|---|---|
| FCF margin | 0.0% |
| FCF conversion (FCF / net income) | 0.0% |
| FCF yield | 0.0% |
| Capex intensity (capex / revenue) | 19.7% |
| FCF − SBC (diagnostic) | $-0.1B |
| Capex split (maint / growth) | 80% / 20% — Insurance is capital-light on physical PP&E; reported capex is IT/systems modernization. The real capital deployment is underwriting capital and float, not fixed assets. |
Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 214% — cash-backed.
Competitive Moat
Moat sources:
- Underwriting scale and global reinsurance capacity
- Investable float generating investment income
- Diversification across P&C lines and geographies
- Actuarial/pricing capability — but replicable by capital-rich peers
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q2): management +0.17 vs analyst floor -0.01 → delta +0.18 (n=25 mgmt / 19 Q&A; 8th pctile across the S&P book, z -1.4).
Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q2 | +0.17 | -0.01 | +0.18 |
| 2026Q1 | +0.28 | +0.00 | +0.28 |
| 2025Q4 | +0.41 | +0.00 | +0.41 |
| 2025Q3 | +0.34 | +0.00 | +0.34 |
News (last 365d, 1174 articles): avg ticker sentiment +0.15 (bullish 18% / bearish 3%)
Consensus & Market Expectations
| Reference | Value |
|---|---|
| Street target (mean) | $406 (+8% vs spot · street) |
| House target | $454 (+11.7% vs street) |
| Sell-side coverage | 16 analysts (SB 3 / B 3 / H 10 / S 0 / SS 0; net score 0.28) |
| Consensus FY EPS | $53.32; house above (+21.7%) |
| Consensus FY revenue | $12.4B; house above (+46.3%) |
_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.
Catalyst Calendar
- 2026-11-01 (~69d) — Atlantic hurricane-season loss tally / cat-load reset (authored)
- 2027-01-01 (~130d) — January 1 reinsurance renewal pricing round (authored)
- 2027-02-25 (~185d) — Prior-year reserve-development disclosure (FY26 reserves) (authored)
Forecast Track Record
- EPS surprise: beat 50% of the last 8 quarters; average surprise -3.1%.
- Prior-forecast backtest (12 snapshots, 2026-06-27→2026-08-20): directional hit-rate 83%; mean predicted +21.4% vs realised +0.7%. Disconfirming track record is reported, not suppressed.
Catalyst Timeline
6 catalysts in the next 90 days (of 16 tracked). Importance 1–3; confidence 0–1.
| When | Catalyst | Type | Importance | Confidence |
|---|---|---|---|---|
| 2026-09-09 (in 15d) | Ex-dividend $2.00/sh | dividend | ● | 0.9 |
| 2026-09-16 (in 22d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-09-18 (in 24d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2026-10-14 (in 50d) | September CPI | macro | ●● | 0.8 |
| 2026-10-28 (in 64d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2026-11-01 (in 68d) | Atlantic hurricane-season loss tally / cat-load reset | authored | ● | 0.7 |
| 2026-12-09 (in 106d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2026-12-18 (in 115d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-01-01 (in 129d) | January 1 reinsurance renewal pricing round | authored | ● | 0.7 |
| 2027-01-27 (in 155d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
| 2027-02-25 (in 184d) | Prior-year reserve-development disclosure (FY26 reserves) | authored | ● | 0.7 |
| 2027-03-17 (in 204d) | FOMC rate decision + SEP dot plot | macro | ●● | 0.8 |
| 2027-03-19 (in 206d) | Quarterly options-expiry cluster (3rd Friday) | opex_cluster | ● | 1.0 |
| 2027-04-28 (in 246d) | FOMC rate decision + press conference | macro | ●● | 0.8 |
_Sources: extended.catalysts, data/catalysts/
Regulatory & Legal Risk
| Issue | Probability | Valuation sensitivity | Horizon |
|---|---|---|---|
| Bermuda/US insurance capital and tax regime changes (corporate minimum tax on Bermuda base) | medium (~35%) | medium - effective tax and capital efficiency ~3-5% of FV | 12-24m |
| Reserve-adequacy scrutiny on long-tail casualty lines (social inflation) | medium (~40%) | high - adverse development hits book value ~5-8% of FV | 12-24m |
Probabilities and sensitivities are analyst estimates, not market-implied.
Scenario Macro & Key Risks
| Scenario | Macro assumption | Key risk |
|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | Social inflation and climate-driven catastrophe frequency structurally raise loss costs while prior-year reserves develop adversely. | Multi-year reserve strengthening erodes book value below the market's assumed floor. |
| Soft Market / Investment Loss | Reinsurance pricing softens as capacity returns while a risk-asset drawdown hits the investment portfolio and float income. | Underwriting and investment income deteriorate together, compressing ROE. |
| Base — Mid-Cycle Combined Ratio | Normal catastrophe year, combined ratio in the low-90s, mid-single-digit premium growth and steady float yield. | An above-average cat year pushes the combined ratio through 100 and turns underwriting profit into loss. |
| Growth — Hard Market / Pricing + Float Income | Sustained hard market keeps rate-on-line elevated while higher reinvestment yields lift float income. | Hard markets attract capital that competes rates back down faster than assumed. |
| Bull — Re-Rate | Clean reserve development plus benign cat losses prove the tail is resolved, re-rating off trough-book toward peer multiples. | A single large loss or reserve charge reverses the re-rate and reopens the tail-risk discount. |
Decision Rules (Machine-Checked)
Stance: Hold — 1 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).
| Rule | Condition | Observed | Triggered |
|---|---|---|---|
| R1-valuation-stretch | expected return vs fair value < -12 (upside_pct) |
20.53 | no |
| R2-valuation-opportunity | expected return vs fair value > 15 (upside_pct) |
20.53 | YES |
| R3-street-revisions | street net rating stance < -0.25 (extended.consensus.street_score) |
0.28 | no |
| R4-earnings-quality | cash conversion of earnings < 80 (extended.accounting_quality.cash_conversion_pct) |
213.8 | no |
| R5-technical-breakdown | price vs 200-day SMA < 0.85 (technicals.sma_200) |
1.12 | no |
| R6-vol-regime-shift | IV/RV vol-risk premium > 1.4 (options_overlay.iv_rv) |
0.97 | no |
Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.
Reasons the Thesis Could Fail (Falsifiable)
Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:
- Combined ratio (reported, consolidated) > 100.0 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
- Adverse prior-year reserve development ($m) > 300.0 (single event). (rationale withheld pending re-authoring — frozen figure or verdict)
- Gross written premium growth (YoY, reinsurance) < 0.0 (2 consecutive prints). Contracting reinsurance premium for two quarters indicates the hard-market pricing tailwind has reversed, removing the volume-and-rate support that both the base and growth cases lean on.
- Net investment income run-rate (YoY change) < -0.1 (2 consecutive prints). Float income is a material earnings pillar. A double-digit decline in net investment income for two prints, absent portfolio de-risking, points to reinvestment-yield pressure that compresses the margin the base case relies on.
- Return on equity (annualised, reported) < 0.09 (2 consecutive prints). (rationale withheld pending re-authoring — frozen figure or verdict)
Fact / Inference / Speculation
- FACT: Spot $377; 52-week range $297–$399; engine rating BUY; house target $454 (+21%). (source: Alpha Vantage 2026-08-24, 25 August 2026)
- INFERENCE: Triangulated FV $554 (+47% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits above the multiple-discipline core.
- SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.
Conviction Score
Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.
60.7/100 (confidence band 47.4–73.9), 61st percentile of 858 covered names (as of 2026-08-24). Weighted composite under config ros-1.19.0 — every component and its inputs below.
| Component | Score (0–100) | Weight | Inputs |
|---|---|---|---|
| business quality | 52 | 15% | extended.fcf_quality.fcf_margin_pct, extended.balance_sheet.net_debt_to_ebitda, extended.accounting_quality.cash_conversion_pct |
| financial strength | — | 10% | extended.balance_sheet.net_debt_to_ebitda, extended.balance_sheet.interest_coverage |
| valuation | 70 | 15% | upside_pct |
| growth | 53 | 10% | reconciliation.ttm_revenue_billions, reconciliation.fy_guide_revenue_billions |
| earnings visibility | 50 | 10% | extended.forecast_accuracy.eps_surprise.beat_rate_pct |
| moat | 52 | 10% | enrichment.moat.rating |
| technical trend (heuristic — no validation record; weight change reserved for AM-060) | 83 | 10% | technicals.rsi, technicals.sma_50, technicals.sma_200 |
| macro tailwinds | — | 10% | industry_context.house |
| risk profile | 64 | 10% | monte_carlo.prob_above_current, monte_carlo.p10, monte_carlo.p90, monte_carlo.median |
Missing inputs (financial strength, macro tailwinds) are excluded and the remaining weights renormalised; the confidence band widens accordingly.
Score history: 60.1 → 60.1 → 60.5 → 59.7 → 59.7 → 60.7 → 60.7 → 60.7.
Probability-Weighted Return Profile
Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.
| Scenario | Probability | Target | Total return | Contribution |
|---|---|---|---|---|
| Structural — Underwriting / Reserve / Catastrophe Reset | 20% | $213 | -43.4% | -8.7pp |
| Soft Market / Investment Loss | 17% | $333 | -11.6% | -2.0pp |
| Base — Mid-Cycle Combined Ratio | 35% | $463 | +22.9% | +8.0pp |
| Growth — Hard Market / Pricing + Float Income | 20% | $626 | +66.1% | +13.2pp |
| Bull — Re-Rate | 8% | $804 | +113.5% | +9.1pp |
| Aggregate | Value |
|---|---|
| Expected return (gross, 1y) | +19.6% |
| Expected return net of SBC dilution | +19.6% |
| Outcome dispersion (σ, from MC p10–p90) | 50.5% |
| Expected Sharpe (rf 4%) | 0.31 |
| Downside expectation (prob-weighted loss branches) | -10.7% |
The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.
Expected Alpha
Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).
| Component | Value |
|---|---|
| Expected return (gross, 1y) | 19.6% |
| Risk-free rate | 4.01% (1y proxy (3m/2y midpoint; AV lacks a 1y tenor), as of 2026-08-13) |
| Beta (shrunk, 1y vs SPY) | 0.33 (as of 2026-08-24) |
| Equity risk premium | 4.5% |
| Required return | 5.5% |
| Expected alpha | +14.1% |
| Alpha per unit risk (EA/σ) | +0.28 |
A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.
Probability Cross-Checks
Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.
| Cross-check | Ours | Comparator | Reading |
|---|---|---|---|
| Scenario spread vs options market | 45.8% (1σ) | 17.2% implied | our scenarios are far wider than the options market prices |
| Mass above spot: scenarios vs our own MC | 63.0% | 56.2% | the two expressions of our own view agree |
| Realised scenario frequency | 23 dated anchors | — | 23 dated anchors available; realised-vs-prior comparison is now meaningful. |
Authored set: 5 scenarios, probabilities summing to 1.0, mean target $450.77.
Flagged for review: scenario spread vs the options market. A flag marks a disagreement worth understanding — it does not imply either side is wrong.
Factor Exposures
Cross-sectional percentiles over 858 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.
| Style | Percentile | Theme | Percentile | |
|---|---|---|---|---|
| Growth | 52 | AI | 11 | |
| Value | 100 | Cloud | 28 | |
| Quality | 8 | Semis | 12 | |
| Momentum | 62 | Consumer | 21 | |
| Low-Vol | 58 | Rates | 9 | |
| USD | 92 | |||
| Energy | 82 |
Market interaction: correlation vs SPY +0.24, vs QQQ +0.12 (trailing ~1y daily returns).
Options Intelligence
Preferred structure: Long Stock. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.
- bullish with fairly-priced options — own the stock; a poor-man's covered call is a leveraged alternative
- Direction bullish from the overlay conviction/rating (read-only input).
- IV/RV at the 55th percentile of the cross-section → mid vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
- Reported alongside and not used to select: this name's own ATM IV sits at the 58th percentile of its own month-end history (decile 6).
- No live-chain Long Stock was priced for this name — shown as the indicated strategy; size against a freshly pulled chain.
IV term structure (flat, slope +1.0pp): 25-DTE 24% · 53-DTE 23% · 235-DTE 25%
No live-chain Long Stock was priced for this name — shown as the indicated approach; size against a fresh chain.
Alternatives: Call Debit Spread. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Position Sizing Framework
| Parameter | Value |
|---|---|
| Initial position | 0.50% NAV |
| Maximum position | 0.83% NAV |
| Risk budget | 1.41% NAV |
| Annualized outcome σ (MC) | 50.5% |
| Indicative holding period | 3–12 months |
| Liquidity | high, ~$119M ADV (adv usd 21 (split-adjusted 21d average, AM-046)), ~0.1 days to exit |
| Rebalancing trigger | position drifts ±25% from target weight, or the decision-rules stance changes |
Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.
Options Overlay
A defined-risk way to express the BUY equity view. Chain as of 2026-08-24 — end-of-day marks — indicative, not executable quotes.
Market signals — ATM IV 23.9% (moderate regime) · expected move ±4.5% (2026-09-18) · put/call OI 0.15 · ATM Δ 0.46 / Θ -0.16 / ν 0.39. Direction: LONG (implied return +27.6% to triangulated fair value $480.62).
Bull Call Spread (Bullish) — Long 380 C / Short 480 C · 2027-04-16 · net debit $25.97 · max profit $74.03 · breakeven $405.98 · RoR 285.0% · max loss $25.97 · priced from the listed chain (EOD marks)
Defined-cost leverage to the fair-value gap: the debit is the entire downside, in exchange for participation between the strikes — a way to lean into upside without paying full call premium. Illustrative — no outcome is implied or guaranteed.
Long Call (LEAPS) (Bullish) — Long 380 C · 2027-04-16 · premium $28.4 · breakeven $408.40 · max loss $28.40 · priced from the listed chain (EOD marks)
Pure defined-risk directional exposure — the premium is the whole downside while the full upside is retained. A capped, known cost as an alternative to owning the shares outright.
Put Spread (income) (Bullish / income) — Short 340 P / Long 320 P · 2026-10-16 · net $0.6 · net entry $339.40 · yield 0.2% · RoR 3.0% · max loss $19.40 · priced from the listed chain (EOD marks)
Gets paid to wait for a lower entry, with the tail capped: the sold put collects premium while the cheaper long wing below it caps the maximum loss at the spread width — a defined-risk alternative to a naked cash-secured put.
Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.
Rating Bridge
Rating = BUY because:
- Probability-weighted scenario value implies +20% vs spot
- Monte Carlo median implies +7% vs spot
- DCF fair value implies +75% vs spot
- Bear case (Structural — Underwriting / Reserve / Catastrophe Reset) downside is -43% vs spot
- Net: reward/risk of 1.1× supports a Buy.
Assumption Register
| Assumption | Value | Used in | Source |
|---|---|---|---|
| SBC dilution | 0.0%/yr | PWEV, MC, DCF (charged once) | estimate (from SBC/rev) |
| EPS basis | consensus forward EPS (broker-adjusted, non-GAAP) | all forward P/E & scenario multiples | definition |
Inputs, Sources & Confidence
Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)
| Input | Value | Type | Source | Confidence | Used in |
|---|---|---|---|---|---|
| Revenue TTM | $17.3B | reported fact | 10-K/10-Q via AV | High | Forecast base, EV/Rev |
| FY+1 guided revenue | $18.2B | company guidance | Company guidance | Medium | Forecast, SoP |
| Consensus FY EPS | $53.3165 | consensus estimate | Sell-side consensus via AV | Medium | Variant perception |
| Diluted shares | 0.038B | reported fact | 10-K via AV | High | Market cap, per-share |
| Net debt / cash | $-15.924B | reported fact | Balance sheet via AV | High | EV, DCF equity bridge |
Research Provenance
| Field | Value |
|---|---|
| Quantitative engine | mch_stock_engine v2.0 |
| Research OS config | ros-1.19.0 |
| Analysis as-of | 2026-08-25 (prices 2026-08-24) |
| Narrative authorship | claude-opus-5 · Claude Code, supervised, drafted 2026-08-16 |
| Human review | Marinus 2026-08-16 |
| Evidence | 8/8 load-bearing inputs sourced; 13/14 mandated claims cited |
| QA | scanned post-emit by the document-QA layer; the publication label (Draft / Research / Decision-level) is stamped on the published page, not authored here |
Load-Bearing Assumptions
DCF inputs (WACC, terminal multiple) are not applicable to this name's valuation adapter; triangulation leans 41% on DCF, 29% on PWEV, 18% on the Monte Carlo median, 12% on peer-implied value.
Appendix & audit trail — source log, data provenance, disclosures
Source Log
| Source | Type | Date | Used for | Reference |
|---|---|---|---|---|
| Alpha Vantage — GLOBAL_QUOTE / OVERVIEW | market data | 2026-08-24 | Price, market cap, EV, forward P/E | Alpha Vantage 2026-08-24 |
| MCH engine — trailing 252 adjusted closes | derived | 2026-08-24 | 52-week range (vendor's recorded range was stale and was replaced) | trailing 252 sessions of own close history; config value was stale |
| Company income statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Revenue, gross/operating margin, EBIT, interest expense | INCOME_STATEMENT / latest annual |
| Company balance sheet (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Cash, debt, net debt, leases, equity, coverage | BALANCE_SHEET / latest annual |
| Company cash-flow statement (10-K / 10-Q) via Alpha Vantage | reported fact | 2026-08-24 | Operating cash flow, capex, FCF, buybacks, dividends, SBC | CASH_FLOW / latest annual |
| Company earnings releases via Alpha Vantage | reported fact | 2026-08-24 | Reported EPS, surprise history | EARNINGS / quarterly |
| Sell-side consensus via Alpha Vantage | consensus estimate | 2026-08-24 | Forward revenue/EPS consensus, analyst count | EARNINGS_ESTIMATES |
| Earnings calendar via Alpha Vantage | market data | 2026-08-24 | Next earnings date, catalyst timing | EARNINGS_CALENDAR |
| Company guidance | company guidance | 2026-08-24 | FY guided revenue / non-GAAP EPS basis | company guidance / earnings call |
| MCH segment model (from filings & disclosures) | house estimate | 2026-08-24 | Segment revenue, margins, multiples, AI decomposition | company_context (authored, tagged) |
| MCH qualitative analysis | inference | 2026-08-24 | Moat, regulatory risk, scenario macro, catalysts | company_context enrichment (authored) |
| MCH investment thesis & falsification triggers | house estimate | 2026-08-24 | Thesis, anti-thesis, thesis-break signals | authored §5.3 |
Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.
Data Sources
- Prices, fundamentals, options chain, earnings — Alpha Vantage.
- Company filings (10-K / 10-Q) — SEC filings via EDGAR.
Disclosures & Limitations
This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.
- This report is produced by the MCH Advisory quantitative research engine — valuation, scenarios, Monte Carlo and the decision layer are generated systematically from the disclosed inputs and the archetype/industry driver sets, and reviewed rather than written name-by-name. Every figure reconciles to the appendix and every score exposes its inputs.
- No suitability assessment has been performed for any individual.
- Market data may be delayed or inaccurate; figures are as of the analysis date.
- Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
- Forecasts are uncertain; past performance is not indicative of future returns.
- The author or publisher may hold positions in securities mentioned.
- Users should verify information against primary sources (company filings) before acting.
- Investing involves risk of loss; there is no guarantee any target price is achieved.
- Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.